Summary:
Study to assess the safety, tolerability and effect of study drug in the treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS).
Qualified Participants Must:
• be over 18 years of age
• have at least a three month history of Constipation-predominant IBS (Irritable Bowel Syndrome)
• have mild abdominal pain or discomfort
Qualified Participants May Receive:
Compensation is offered for time and travel, please inquire for details.